5-hydroxydecanoate has been researched along with geranylgeranylacetone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, M; Kohno, H; Murozono, Y; Ooie, T; Saikawa, T; Shimada, T; Shinohara, T; Takahashi, N; Taniguchi, Y; Torigoe, Y; Wakisaka, O; Yamanaka, K; Yoshimatsu, H | 1 |
| Abe, E; Abe, T; Fujiki, M; Ishii, K; Kobayashi, H; Kubo, T; Nagai, Y; Shiqi, K | 1 |
2 other study(ies) available for 5-hydroxydecanoate and geranylgeranylacetone
| Article | Year |
|---|---|
Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Ulcer Agents; Cell Respiration; Cells, Cultured; Creatine Kinase, MB Form; Decanoic Acids; Diterpenes; Gene Expression Regulation; Glyburide; HSP72 Heat-Shock Proteins; Hydroxy Acids; Male; Mitochondria, Heart; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Potassium Channels; Rats; Rats, Sprague-Dawley; RNA, Small Interfering | 2007 |
The phosphatidylinositol-3 kinase/Akt pathway mediates geranylgeranylacetone-induced neuroprotection against cerebral infarction in rats.
Topics: Androstadienes; Animals; Brain; Brain Infarction; Central Nervous System Agents; Decanoic Acids; Diazoxide; Diterpenes; Enzyme Inhibitors; Hydroxy Acids; Infarction, Middle Cerebral Artery; KATP Channels; Male; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Time Factors; Wortmannin | 2010 |